TY  - GEN
AU  - Swindells,Susan
AU  - Ramchandani,Ritesh
AU  - Gupta,Amita
AU  - Benson,Constance A
AU  - Leon-Cruz,Jorge
AU  - Mwelase,Noluthando
AU  - Jean Juste,Marc A
AU  - Lama,Javier R
AU  - Valencia,Javier
AU  - Omoz-Oarhe,Ayotunde
AU  - Supparatpinyo,Khuanchai
AU  - Masheto,Gaerolwe
AU  - Mohapi,Lerato
AU  - da Silva Escada,Rodrigo O
AU  - Mawlana,Sajeeda
AU  - Banda,Peter
AU  - Severe,Patrice
AU  - Hakim,James
AU  - Kanyama,Cecilia
AU  - Langat,Deborah
AU  - Moran,Laura
AU  - Andersen,Janet
AU  - Fletcher,Courtney V
AU  - Nuermberger,Eric
AU  - Chaisson,Richard E
TI  - One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis
SN  - 1533-4406
PY  - 2019///0325
KW  - AIDS-Related Opportunistic Infections
KW  - prevention & control
KW  - Adult
KW  - Antitubercular Agents
KW  - administration & dosage
KW  - CD4 Lymphocyte Count
KW  - Drug Administration Schedule
KW  - Drug Therapy, Combination
KW  - Female
KW  - HIV Infections
KW  - complications
KW  - Humans
KW  - Isoniazid
KW  - Latent Tuberculosis
KW  - Male
KW  - Medication Adherence
KW  - Rifampin
KW  - Tuberculosis
N1  - Publication Type: Clinical Trial, Phase III; Comparative Study; Equivalence Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1056/NEJMoa1806808
ER  -